mRNA cancer vaccine succeeds in Phase III melanoma
The discussion presented the positive Phase III results for Moderna and Merck's personalized mRNA cancer vaccine (Intismeran) combined with Keytruda as a breakthrough, marking the first successful cancer vaccine after over a thousand failed trials.
Keep reading this one
You've read the thesis and who argued it. A free account opens the argument, what validates it, the risks the show raised, and the moment in the episode where it was said — 3 ideas in full a day, no card.